Filing Details

Accession Number:
0001140361-14-040356
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-05 19:44:08
Reporting Period:
2014-10-31
Filing Date:
2014-11-05
Accepted Time:
2014-11-05 19:44:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557533 Robert Jeffrey Ajer C/O Biomarin Pharmaceutical Inc.,
105 Digital Drive
Novato CA 94949
Svp, Chief Commercial Of No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-31 47 $31.26 31,637 No 5 A Direct
Common Stock Disposition 2014-11-03 47 $83.54 31,590 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
Footnotes
  1. The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 1, 2014 to October 31, 2014.
  2. Transaction made pursuant to a Rule 10b5-1 trading plan executed on December 12, 2013.
  3. All shares sold at same price